Semaglutide is not currently licensed for use in children under the age of 12, and safety evidence for its use in high-risk geriatric groups is limited [16]
Smart meal timing, portion control, and adequate hydration are crucial in managing potential side effects and supporting weight management goals
Check blood ketones if your blood glucose exceeds 13.9 mmol/L or if you feel unwell, particularly during illness
Individual results vary significantly, and factors like starting weight, diet, exercise, and genetics all influence outcomes
[14] [23] Rybelsus (semaglutide tablets) was approved in September 2019 as the first oral GLP-1 receptor agonist for type 2 diabetes management
Mood and energy swings: Both fasting and GLP-1s can affect mood and energy, particularly when starting intermittent fasting or adjusting medication doses